Shingles vaccination can cut older adults’ risk of developing dementia, study says
- A new study found shingles vaccination cut older adults' risk of developing dementia over the next seven years by 20%.
- The study tracked people in Wales who were around 80 when receiving the world's first-generation shingles vaccine over a decade ago.
- Now, Americans 50 and older are urged to get a newer vaccine that's proven more effective against shingles than its predecessor.
59 Articles
59 Articles
A Shingles Vaccine Policy Paved Way for a Stunning Find
In late 2013, Wales changed its shingles vaccine policy: Those people born on or after Sept. 2, 1933, could receive the Zostavax shot; those born before that date could not. The Guardian reports it "created a natural experiment," and one that researchers say now indicates the vaccine does reduce the...
Shingles vaccine may lower dementia risk by 20% in older adults, study shows
The shingles vaccine reduced the risk of dementia by 20% among older adults, new research shows. Cases of dementia and Alzheimer's disease – the most common form of dementia – are skyrocketing around the world. Finding an intervention could be a difference maker, researchers say.
Coverage Details
Bias Distribution
- 46% of the sources lean Left
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage